GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alphamab Oncology (HKSE:09966) » Definitions » Machinery, Furniture, Equipment

Alphamab Oncology (HKSE:09966) Machinery, Furniture, Equipment

: HK$0.0 Mil (As of Jun. 2023)
View and export this data going back to 2019. Start your Free Trial

Alphamab Oncology's Machinery, Furniture, Equipment for the quarter that ended in Jun. 2023 was HK$0.0 Mil.

Alphamab Oncology's quarterly Machinery, Furniture, Equipment increased from Jun. 2022 (HK$0.0 Mil) to Dec. 2022 (HK$319.7 Mil) but then declined from Dec. 2022 (HK$319.7 Mil) to Jun. 2023 (HK$0.0 Mil).

Alphamab Oncology's annual Machinery, Furniture, Equipment increased from Dec. 2020 (HK$143.0 Mil) to Dec. 2021 (HK$186.7 Mil) and increased from Dec. 2021 (HK$186.7 Mil) to Dec. 2022 (HK$319.7 Mil).


Alphamab Oncology Machinery, Furniture, Equipment Historical Data

The historical data trend for Alphamab Oncology's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphamab Oncology Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Machinery, Furniture, Equipment
Premium Member Only Premium Member Only 38.83 143.02 186.68 319.72 420.90

Alphamab Oncology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Machinery, Furniture, Equipment Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 186.68 - 319.72 - 420.90

Alphamab Oncology Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


Alphamab Oncology (HKSE:09966) Business Description

Industry
Traded in Other Exchanges
Address
No. 175 Fangzhou Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215024
Alphamab Oncology is a clinical-stage biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecifics and protein engineering. The company through its subsidiaries is engaged in discovery, development manufacturing and commercialization of biotherapeutics for cancer treatment.

Alphamab Oncology (HKSE:09966) Headlines

No Headlines